Protective effects of pergolide in a 6-hydroxydopamine model of Parkinson's disease

被引：0
|
作者：
Ciobica, A.
Hritcu, L.
Artenie, V.
Padurariu, M.
机构：
[1] Alexandru Ioan Cuza Univ, Iasi, Romania
[2] Gr T Popa Univ, Socola Hosp, Iasi, Romania
来源：
JOURNAL OF NEUROLOGY | 2010年 / 257卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P194
引用
收藏
页码：S62 / S62
页数：1
相关论文
共 50 条
  • [21] NEUROPROTECTIVE EFFECTS OF SWIMMING TRAINING IN A MOUSE MODEL OF PARKINSON'S DISEASE INDUCED BY 6-HYDROXYDOPAMINE
    Goes, A. T. R.
    Souza, L. C.
    Filho, C. B.
    Del Fabbro, L.
    De Gomes, M. G.
    Boeira, S. P.
    Jesse, C. R.
    NEUROSCIENCE, 2014, 256 : 61 - 71
  • [22] Behavioral and Histological Effects of Lipopolysaccharide Preconditioning in a 6-Hydroxydopamine Rat Model of Parkinson's Disease
    Golpich, M.
    Amini, E.
    Mohamed, Z.
    Raymond, A. A.
    Norlinah, M. I.
    Ahmadiani, A.
    PUBLIC HEALTH GENOMICS, 2015, 18 : 37 - 37
  • [23] Neuroprotection by safinamide in the 6-hydroxydopamine (6-OHDA) model of Parkinson's disease
    Sadeghian, M.
    Roach, A.
    Smith, K. J.
    MOVEMENT DISORDERS, 2011, 26 : S286 - S286
  • [24] Protective efficacy of P7C3-S243 in the 6-hydroxydopamine model of Parkinson's disease
    De Jesús-Cortés H.
    Miller A.D.
    Britt J.K.
    DeMarco A.J.
    De Jesús-Cortés M.
    Stuebing E.
    Naidoo J.
    Vázquez-Rosa E.
    Morlock L.
    Williams N.S.
    Ready J.M.
    Narayanan N.S.
    Pieper A.A.
    npj Parkinson's Disease, 1 (1)
  • [25] Sensorimotor assessment of the unilateral 6-hydroxydopamine mouse model of Parkinson's disease
    Glajch, Kelly E.
    Fleming, Sheila M.
    Surmeier, D. James
    Osten, Pavel
    BEHAVIOURAL BRAIN RESEARCH, 2012, 230 (02) : 309 - 316
  • [26] Exercise-Induced Neuroprotection in the 6-Hydroxydopamine Parkinson’s Disease Model
    Zeinab Rezaee
    Sayed Mohammad Marandi
    Hojjatallah Alaei
    Fahimeh Esfarjani
    Neurotoxicity Research, 2020, 38 : 850 - 858
  • [27] Thrombin preconditioning provides protection in a 6-hydroxydopamine Parkinson's disease model
    Cannon, JR
    Keep, RF
    Hua, Y
    Richardson, RJ
    Schallert, T
    Xi, GH
    NEUROSCIENCE LETTERS, 2005, 373 (03) : 189 - 194
  • [28] Characterization of the gastrointestinal dysfunction in the 6-hydroxydopamine rat model of Parkinson's disease
    Chai, X.
    Diwakarla, S.
    Pustovit, R.
    McQuade, R.
    Di Natale, M.
    Ermine, C.
    Parish, C.
    Finkelstein, D.
    Furness, J.
    MOVEMENT DISORDERS, 2019, 34 : S629 - S629
  • [29] Exercise-Induced Neuroprotection in the 6-Hydroxydopamine Parkinson's Disease Model
    Rezaee, Zeinab
    Marandi, Sayed Mohammad
    Alaei, Hojjatallah
    Esfarjani, Fahimeh
    NEUROTOXICITY RESEARCH, 2020, 38 (04) : 850 - 858
  • [30] GDNF reduces oxidative stress in a 6-hydroxydopamine model of Parkinson's disease
    Smith, Michael P.
    Cass, Wayne A.
    NEUROSCIENCE LETTERS, 2007, 412 (03) : 259 - 263
12345